🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#Tandem24 #lymsm #Cartrx Stop by poster 487 this evening to discuss CAR-T for treatment of patients with T-cell Histiocyte Rich Large B-Cell Lymphoma! TL/DR: not a panacea (as in all LBCL) but there *is* a proportion with response. *¿would this subset benefit from adding PD1i?*

It's time for this year's #MajorPROsASCO, the top 20 patient-reported outcomes (PROs) & quality of life abstracts at #ASCO24! I'll be updating this thread throughout the conference as I visit the posters and orals. 🧵 cc ASCO

Does anyone know if they collected PROs as part of ECHELON-3? I can't find anything online. Dr. Priyanka Pophali, MD brought up a phenomenal point that PROs would provide important context to this OS benefit, especially from #gerionc angle. #ASCO24 #lymsm

The L-THORs (Lymphoma Translational Health Outcomes Researchers) are on duty at #ASCO24! We're passionate about translating outcomes science and PROs into trials and real-world practice. #lymsm #heor

Dr. Priyanka Pophali, MD gives a masterful synopsis of the GHSG HD21 results, with a focus on less transfusion support, neuropathy, and gonadotoxicity from BrECADD. And a call for PROs from the podium! #ASCO24 #lymsm

What an incredible feeling to present my first #ASCO24 talk ever! Grateful for the opportunity! Hem malignancy highlights from Day 1: UW Health | Carbone Cancer Center UW Hematology-Oncology and Palliative Care University of Wisconsin Department of Medicine Women in Lymphoma - [email protected]

Always awesome to reconnect with old connections!! So proud of the work you’re doing Saurabh Zanwar!! #Nagpur@#ASCO24!

#ASCO2014 to #ASCO2024 Short trip to ASCO, but great to celebrate 10 years ASCO’ing with ⁦Priyanka Pophali, MD⁩

Congratulations and welcome to WiL's new *Sub-Committee Emerging Collaborators* 🌏🩺 Allison Barraclough @OncDocBock Supriya Gupta, MD Avyakta Kallam Swetha Kambhampati Patrizia Mondello, MD, PhD, MSc Priyanka Pophali, MD Tarsheen Sethi, MD, MSCI Pallawi Torka Yun Kyoung Ryu

Interested in how you can incorporate patient-reported outcomes (PROs) into your hematology clinical trials to measure treatment tolerability? Check out our latest review, with PRO gurus Drs. Amylou Dueck, PhD & Gita Thanarajasingam. #lymsm #leusm #mmsm clinical-lymphoma-myeloma-leukemia.com/article/S2152-…

It was a fun exchange! Thanks for hosting the meeting Timothy Schmidt, MD!

Thanks manalikamdar for your insightful commentary on our CIBMTR study looking at outcomes of CD19 #CART in THRLBCL! It was great collaborating with Joshua Fein Mazyar Shadman, MD MPH Roni Shouval Mehdi Hamadani, MD on this study! ashpublications.org/bloodadvances/…

That’s the debate. I’ve transplanted isolated SCNSL relapse that’s >12 months after frontline treatment. I’ve done CART if they received CNS ppx and still relapsed. An early CNS relapse makes me wonder if the second line CART approach is the right one? Narendranath Epperla, MD, MS, FACP

Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: Phase III CLL12 Trial shows watch and wait still remains the standard. Journal of Clinical Oncology The SWOG Cancer Research Network S1925 trial is asking a similar question with venetoclax. Deborah Stephens ascopubs.org/doi/full/10.12…

#ASH24 Day 1 with the OG Dr. Pophali (my dad) and dinner with my lymphoma family UW Hematology-Oncology and Palliative Care Christopher Fletcher Looking forward to catching up with many more friends and colleagues!

Congratulations to Dr Dipti Jain on Ham Wasserman Lecture! Incredible work on addressing sickle cell disease in India ASH Dr. Mohan Narla #ASH24

Such richly deserved recognition for an amazing teacher! Decades long selfless service to the patients and the field! Fills me with so much happiness to see Dr. Jain on stage! We were very fortunate to be trained by her! #ASHKudos #ASH24

⚕️ Women in Lymphoma - [email protected] Steering Committee members, advocates, sponsors and supporters from all over the world🌍networking and sharing connections, initiatives and experience at #ASH24 #lymsm #lymphoma ASH